Background Heart failure with preserved ejection fraction (HF p EF) constitutes half of
hospitalized heart failure cases and is commonly associated with obesity. The role of …

B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure Tamara B.
Horwich, Michele A. Hamilton, Gregg C. Fonarow Although recent studies show that obesity …

Concentrations of both B-type natriuretic peptide (BNP) and its amino-terminal cleavage
fragment (NT-proBNP) are relatively lower among patients with a higher body mass index …

Aims Obese patients have lower natriuretic peptide concentrations. We hypothesized that
adjusting the concentration of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) for …

Background Levels of B-type natriuretic peptide (BNP), a prognostic marker in patients with
heart failure (HF), are lower among HF patients with obesity or preserved Left Ventricular …

BACKGROUND: Obesity may reduce diagnostic accuracy of B-type natriuretic peptide (BNP)
and affect long-term outcome. METHODS: This study evaluated patients included in the …

BACKGROUND: Obesity is associated with lower B-type natriuretic peptide (BNP) levels in
healthy individuals and patients with chronic congestive heart failure (CHF). Neither the …

Background Higher body mass index (BMI) is associated with lower circulating levels of N‐
terminal‐pro‐b‐type natriuretic peptide (NT‐pro BNP). The Interaction between BMI and NT …

Background: BNP and N-terminal proBNP (NT-proBNP) concentrations may be depressed
in patients with increased body mass index (BMI). Whether increased BMI affects accuracy …

Natriuretic peptides (NPs, B-type natriuretic peptide/BNP and NT-proBNP) are universally
used biomarkers with established cut-points to aid in the diagnosis of heart failure (HF). It …